| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRATHECAL | 176 mg | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM LAURETH SULFATE | SODIUM LAURETH-3 SULFATE | BPV390UAP0 | SHAMPOO / TOPICAL | | 3192 mg | Exact identifier — unii candidate 5 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE, DELAYED RELEASE / ORAL | 0.25 mg | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / INTRADISCAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | POWDER, FOR SUSPENSION / ORAL | | 8 mg | Exact identifier — unii candidate 68 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / IRRIGATION | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | ELIXIR / ORAL | 800 mg | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / PARENTERAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / URETHRAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CONCENTRATE / ORAL | 2.5 mg/5ml | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / NASAL | 26 mg | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | POWDER / ORAL | NA | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | EMULSION / OPHTHALMIC | 0.02 %w/v | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | LIQUID / ORAL | 2 mg/5ml | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | TABLET / ORAL | NA | | Exact identifier — unii candidate 15 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LOTION / TOPICAL | | 351 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRATHECAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / PERINEURAL | | 80 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAPERITONEAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / SOFT TISSUE | 0.15 %w/v | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / PARENTERAL | | 30 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRATUMOR | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRASYNOVIAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | AEROSOL, FOAM / TOPICAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTABLE, LIPOSOMAL / INTRAVENOUS | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRA-ARTERIAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION / INTRAVITREAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | SOLUTION / RECTAL | 0.01 %w/v | | Exact identifier — unii candidate 15 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / INTRAVENOUS | | 6 mg | Exact identifier — unii candidate 68 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CAPSULE / ORAL | | 1 mg | Exact identifier — unii candidate 68 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | MOUTHWASH / BUCCAL | 2 mg/1ml | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | CREAM, AUGMENTED / TOPICAL | | 2 mg | Exact identifier — unii candidate 68 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CAPSULE / ORAL | | 7 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / SUBCUTANEOUS | | 2 mg | Exact identifier — unii candidate 68 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | JELLY / TOPICAL | | 420 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRAOCULAR | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | POWDER / RESPIRATORY (INHALATION) | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRATHECAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | TABLET / ORAL | 0.2 mg | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SOLUTION / ORAL | | 126 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / PARENTERAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | TABLET, CHEWABLE / ORAL | 1.28 mg | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | FILM / BUCCAL | 0.09 mg | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / AURICULAR (OTIC) | NA | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | DROPS / ORAL | NA | | Exact identifier — unii candidate 15 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | POWDER, FOR SUSPENSION / ENDOTRACHEAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 78.36 mg | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / RECTAL | 0.13 %w/v | | Exact identifier — unii candidate 79 equally ranked IID candidates |
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | LOTION / TOPICAL | | 4 mg | Exact identifier — unii candidate 15 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SHAMPOO / TOPICAL | 0.03 %w/w | | Exact identifier — unii candidate 68 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | CAPSULE, EXTENDED RELEASE / ORAL | | 2 mg | Exact identifier — unii candidate 79 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SPRAY / NASAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | NA | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | CREAM / VAGINAL | 0.19 %w/w | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | LIQUID / INTRAVENOUS | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION, CONCENTRATE / INTRAVENOUS | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | SUSPENSION / ORAL | | 12 mg | Exact identifier — unii candidate 15 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | TABLET, FILM COATED / ORAL | | 8 mg | Exact identifier — unii candidate 174 equally ranked IID candidates |
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | ENEMA / RECTAL | 0.02 %w/w | | Exact identifier — unii candidate 68 equally ranked IID candidates |